898069066	898069066	CD	B-NP	O
|	|	NN	I-NP	O
CCH	CCH	NN	I-NP	O
|	|	NN	I-NP	O
49521159	49521159	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7978479	7978479	CD	B-NP	O
|	|	CC	I-NP	O
10/28/2003	10/28/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NECROTIZING	NECROTIZING	NNP	I-NP	I-protein
FASCIITIS	FASCIITIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/1/2003	7/1/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/25/2003	9/25/2003	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
NECROTIZING	NECROTIZING	VBG	B-VP	O
FASCIITIS	FASCIITIS	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
73-year-old	73-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	O	O
critical	critical	JJ	B-NP	O
AS	AS	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
Er	Er	NN	I-NP	B-protein
/	/	SYM	B-NP	O
Neslath	Neslath	NN	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Of	Of	IN	B-PP	O
office	office	NN	B-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
thigh	thigh	NN	I-NP	O
mass	mass	NN	I-NP	O
present	present	JJ	I-NP	O
x	x	NN	I-NP	O
4	4	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
abscess	abscess	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
with	with	IN	B-PP	O
chills	chill	NNS	B-NP	O
and	and	CC	I-NP	O
fevers	fever	NNS	I-NP	O
to	to	TO	B-PP	O
102	102	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
had	have	VBD	B-VP	O
become	become	VBN	I-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
start	start	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
tachycardic	tachycardic	JJ	I-NP	O
and	and	CC	I-NP	O
hypotensive	hypotensive	JJ	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Past	Past	NNP	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
includes	include	VBZ	B-VP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
critical	critical	JJ	B-NP	O
AS	AS	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
anemia	anemia	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
include	include	VBP	B-VP	O
Glyburide	Glyburide	NN	B-NP	O
,	,	,	O	O
Metformin	Metformin	NN	B-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Zestril	Zestril	NNP	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Allergies	Allergy	NNS	B-NP	O
include	include	VBP	B-VP	O
Penicillin	Penicillin	NNP	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
here	here	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Merso	Merso	NNP	I-NP	O
Ri	Ri	NNP	I-NP	O
Riska	Riska	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
101.5	101.5	CD	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
128	128	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
103/52	103/52	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
breathing	breathe	VBG	I-VP	O
regularly	regularly	RB	B-ADVP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
generally	generally	RB	B-ADVP	O
a	a	DT	B-NP	O
mildly	mildly	RB	I-NP	O
ill	ill	RB	B-VP	O
appearing	appear	VBG	I-VP	O
obese	obese	JJ	B-NP	O
female	female	NN	I-NP	O
.	.	.	O	O

Cardiovascularly	Cardiovascularly	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
tachycardic	tachycardic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
regular	regular	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
louder	louder	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
obese	obese	JJ	I-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
audible	audible	JJ	B-NP	O
but	but	CC	I-NP	O
low	low	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
trace	trace	NN	B-NP	O
guaiac-positive	guaiac-positive	JJ	B-ADJP	O
by	by	IN	B-PP	O
report	report	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
right	right	JJ	I-NP	O
thigh	thigh	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
boil	boil	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
pannus	pannus	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
,	,	,	O	O
tenderness	tenderness	NN	B-NP	O
down	down	RP	B-PRT	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
and	and	CC	B-PP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
groin	groin	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
labial	labial	JJ	I-NP	O
or	or	CC	I-NP	O
perirectal	perirectal	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
73	73	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
3.8	3.8	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
357	357	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
18.4	18.4	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
inversion	inversion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
UA	UA	NNP	I-NP	O
showed	show	VBD	B-VP	O
some	some	DT	B-NP	O
trace	trace	NN	I-NP	O
blood	blood	NN	I-NP	O
and	and	CC	O	O
trace	trace	NN	B-NP	B-protein
leukocyte	leukocyte	NN	I-NP	I-protein
esterase	esterase	NN	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
emergently	emergently	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
incision	incision	NN	I-NP	O
and	and	CC	I-NP	O
drainage	drainage	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
necrotizing	necrotizing	JJ	I-NP	O
fasciitis	fasciitis	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
intubated	intubated	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Surgical	Surgical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
NeoFed	NeoFed	NNP	B-NP	O
for	for	IN	B-PP	O
control	control	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
it	it	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
70s	70	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
receiving	receive	VBG	I-VP	O
metoprolol	metoprolol	NN	B-NP	O
and	and	CC	I-NP	O
esmolol	esmolol	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
gone	go	VBN	I-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
130s	130	NNS	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
triple	triple	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
for	for	IN	B-PP	O
full	full	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
awake	awake	NN	B-NP	O
and	and	CC	O	O
appeared	appear	VBD	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
on	on	IN	B-PP	O
fentanyl	fentanyl	NN	B-NP	O
for	for	IN	B-PP	O
analgesia	analgesia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
Brookstibu	Brookstibu	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
need	need	VB	I-VP	O
Levophed	Levophed	NNP	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	I-NP	O
EKGs	EKG	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
being	be	VBG	I-VP	O
continuously	continuously	RB	I-VP	O
followed	follow	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
ventilator	ventilator	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
Plastic	Plastic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
for	for	IN	B-PP	O
future	future	JJ	B-NP	O
necessitating	necessitate	VBG	I-NP	O
closure	closure	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
right	right	JJ	I-NP	O
thigh	thigh	NN	I-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
improving	improve	VBG	I-VP	O
,	,	,	O	O
NG	NG	NN	B-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

By	By	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
feeling	feel	VBG	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
Percocet	Percocet	NNP	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
wound	wound	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
healthy	healthy	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
necessitate	necessitate	VB	I-VP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
drip	drip	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
cultures	culture	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
showed	show	VBD	B-VP	O
positive	positive	JJ	B-NP	O
Enterococci	Enterococci	NNP	I-NP	O
and	and	CC	I-NP	O
Corynebacter	Corynebacter	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
microbes	microbe	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
nursing	nursing	NN	I-NP	O
floor	floor	NN	I-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
regular	regular	JJ	I-NP	O
nursing	nursing	NN	I-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
tolerating	tolerate	VBG	B-VP	O
all	all	DT	B-NP	O
her	her	PRP$	I-NP	O
diabetes	diabetes	NN	I-NP	O
meds	med	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
140/70s	140/70s	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
ranging	range	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
70-75s	70-75	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
8	8	CD	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
VAC	VAC	NN	I-NP	O
sponge	sponge	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
,	,	,	O	O
rehab	rehab	NN	B-NP	O
screening	screening	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
9	9	CD	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
working	work	VBG	I-VP	O
with	with	IN	B-PP	O
Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
tolerating	tolerate	VBG	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
stable	stable	JJ	I-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
wound	wound	NN	I-NP	O
showed	show	VBD	B-VP	O
healthy	healthy	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
VAC	VAC	NN	I-NP	O
sponge	sponge	NN	I-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
triple	triple	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
day	day	NN	B-NP	O
9	9	CD	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
21-day	21-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
is	be	VBZ	B-VP	O
dosed	dose	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
depending	depend	VBG	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
also	also	RB	B-ADVP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Malady	Malady	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Plastic	Plastic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
closure	closure	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Princoness	Princoness	NNP	I-NP	O
-	-	HYPH	I-NP	O
Caken	Caken	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
include	include	VBP	B-VP	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
5000	5000	CD	I-NP	O
U	U	NN	I-NP	O
subcu	subcu	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
day	day	NN	I-NP	I-protein
9	9	CD	B-NP	I-protein
of	of	IN	B-PP	O
21	21	CD	B-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
1-2	1-2	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.4-6h	q.4-6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
therapeutic	therapeutic	JJ	B-ADJP	O
with	with	IN	B-PP	O
minerals	mineral	NNS	B-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
q.d.	q.d.	NN	I-NP	O
dosed	dose	VBD	B-VP	O
daily	daily	RB	B-ADVP	O
only	only	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
daily	daily	JJ	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
lab	lab	NN	I-NP	O
levels	level	NNS	I-NP	O
are	be	VBP	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
15	15	CD	I-NP	O
,	,	,	I-NP	O
zinc	zinc	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
220	220	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
esomeprazole	esomeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
ADA	ADA	NN	B-NP	B-protein
,	,	,	O	O
2100	2100	CD	B-NP	O
calories	calorie	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ACTIVITY	ACTIVITY	NN	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
restrictions	restriction	NNS	I-NP	O
,	,	,	O	O
elevate	elevate	VBP	B-VP	O
feet	foot	NNS	B-NP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
prolonged	prolonged	JJ	I-NP	O
sitting	sit	VBG	I-NP	O
periods	period	NNS	I-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
noted	note	VBN	B-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bardes	Bardes	NNP	I-NP	O
,	,	,	O	O
Plastic	Plastic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Sisterswe	Sisterswe	NNP	B-NP	O
University	University	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Care	Care	NNP	I-NP	O
followup	followup	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
NORRIS	NORRIS	NNP	B-NP	O
RIGGERT	RIGGERT	NNP	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KARL	KARL	NNP	B-NP	O
HOAGUE	HOAGUE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JE31	JE31	NNP	I-NP	O
EZ969/845463	EZ969/845463	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
1966	1966	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

HNBG8X00KC	HNBG8X00KC	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
5/30/03	5/30/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/30/03	5/30/03	CD	B-NP	O

